Skip to main navigation Skip to search Skip to main content

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

  • Viktor Grünwald
  • , Pierre I. Karakiewicz
  • , Sevil E. Bavbek
  • , Kurt Miller
  • , Jean Pascal Machiels
  • , Se Hoon Lee
  • , James Larkin
  • , Petri Bono
  • , Sun Young Rha
  • , Daniel Castellano
  • , Christian U. Blank
  • , Jennifer J. Knox
  • , Robert Hawkins
  • , Oezlem Anak
  • , Marianne Rosamilia
  • , Jocelyn Booth
  • , Nicoletta Pirotta
  • , István Bodrogi
  • , M. Romedi
  • , S. Ferrandini
    • M. Rondinon, K. Pittman, D. Goldstein, J. Shapiro, S. Troon, D. Yip, P. Mainwaring, R. Zigeuner, W. Loidl, R. F. Greil, M. Schmidinger, J. De Grève, S. Rottey, J. Vermorken, J. Machiels, T. Gil, C. Gennigens, T. Roumeguere, C. Barrios, C. Mathias, H. Assi, S. Hotte, P. Karakiewicz, J. Knox, S. Spadafora, L. Wood, P. Zalewski, M. Mackensie, G. Bjarnason, A. Lalancette, A. Chan, B. Higgins, S. North, D. Soulieres, J. Asselah, C. Sperlich, W. Miller, S. Yadav, R. El-Maraghi, J. Godoy, J. Prausová, J. Katolicka, L. Petruzelka, I. Kiss, P. Bono, M. Lapela, K. Miller, L. Bergmann, J. Beck, E. Jäger, M. Kindler, F. Overkamp, M. Wirth, W. Hölzer, J. Gschwend, A. Stenzl, T. Gauler, D. Niederwieser, N. Marschner, A. Lück, H. Tessen, C. Eichelberg, T. Steiner, P. Goebell, E. Kettner, A. Bakhshandeh-Bath, M. Wilhelm, S. Schmitz, A. Jacob, S. Bierer, U. Kube, M. Staehler, E. Engel, M. Frambach, U. Schellenberger, P. Albers, J. Simon, M. Gleissler, T. Klotz, R. Repp, H. Kröning, J. Westermann, U. Rebmann, B. Brehmer, N. Niederle, C. Grund, K. Verpoort, P. Fonara, J. Rassweiler, A. Bamias, G. Fountzilas, E. Razis, D. Mouratidou, V. Georgoulias, E. Samantas, I. Bodrogi, L. Mangel, J. Szanto, R. Berger, A. Pe'er, A. Sella, R. Ben-Yosef, H. Nechushtan, L. Crinò, S. Bracarda, L. Ciuffreda, C. Graiff, A. Falcone, M. Roselli, C. Sternberg, A. Santoro, E. Ruggeri, A. Bearz, M. Venturini, M. Aglietta, D. Amadori, F. Di Costanzo, M. Bari, N. Gebbia, P. Conte, A. Bonetti, R. Bordonaro, S. Cascinu, A. Contu, G. Cruciani, D. Gasparro, M. Nardi, G. Lelli, G. Lo Re, F. Boccardo, V. Lorusso, E. Maiello, P. Manente, R. Passalacqua, F. Piantedosi, C. Porta, C. Sacco, C. Tondini, S. De Placido, G. Carteni, L. Dogliotto, G. Rosti, M. Milella, F. Roila, D. Amoroso, G. Farina, H. Al-Khatib, S. Lee, T. Kim, J. Ahn, H. Lim, I. Chung, J. Kim, J. Chung, M. Ghosn, A. Shameseddine, R. Lugo, P. Cabrera, S. Osanto, G. Groenewegen, C. Blank, F. van den Eertwegh, C. van Herpen, S. Oosting, P. Soetekouw, W. Lilleby, O. Klepp, T. Guren, J. Alcedo, P. Karlov, D. Nosov, L. Roman, I. Rusakov, S. Bazarbashi, C. Toh, J. Mardiak, M. Constenla, F. Garcia del Muro Solans, J. Maroto Ray, J. Bellmunt Mollins, D. Castellano, I. Duran Martinez, B. Mellado Gonzalez, M. Domenech Santasusana, M. Lopez-Brea Piqueras, J. Campillo Fuentes, J. Gonzalez Larriba, R. Luque Caro, A. Meana Garcia, L. Aparicio, N. Batista Lopez, V. Calderero Aragon, C. Valverde Morales, M. Figueiras, J. Contreras Ibanez, E. Gonzalez Billalabeitia, E. Estrada, J. Arranz, J. Lambea Sorrosal, A. Lozano, M. Codes de Villena, E. Espinosa, R. Lopez, J. Perez Garcia, A. Laurell, U. Stierner, M. Cwikiel, M. Borner, P. Y. Dietrich, C. Rothermundt, Y. Pu, Y. Chang, Y. Ou, C. Chuang, Y. Liao, V. Srimuninnimit, V. Sriuranpong, S. Buyukberber, B. Yalcin, E. Goker, S. Yalcin, T. Geldart, J. Wagstaff, S. Nicholson, S. Chowdhury, A. Bahl, R. Jones, A. Azzabi, D. Chao, K. Fife, R. Hawkins, G. Mead, P. Nathan, H. Pandha, J. Hajdenberg, N. Gabrail, N. Nimeh, T. Logan, T. Flaig, R. Schraeder, B. Rini, M. O'Rourke, C. Alemany, J. Beck, A. Kessinger, A. Amin, M. Arriaga, J. Rodriguez
  • Hannover Medical School
  • Centre Hospitalier de L'Universite de Montreal
  • Istanbul University
  • Charité – Universitätsmedizin Berlin
  • Université catholique de Louvain
  • Seoul National University
  • Royal Marsden NHS Foundation Trust
  • Helsinki University Hospital
  • Yonsei University
  • Hospital Universitario 12 de Octubre
  • Netherlands Cancer Institute
  • Princess Margaret Cancer Centre
  • The Christie NHS Foundation Trust
  • Novartis
  • National Institute of Oncology

Research output: Contribution to journal › Article › peer-review

84   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science